📈 SPC Achieves Record Financial Turnaround in 2025

The State Pharmaceuticals Corporation (SPC) reported a landmark year in 2025, marked by a massive surge in government contributions and historic operational milestones. • Fiscal Performance • Total contribution to the Government (taxes and levies) surged by 173% YoY to Rs. 1.1 billion. • Revenue from the Own Revenue Stream (ORS) increased by 26%. • Production within the ORS grew by 36% YoY, reflecting a sharp rise in operational efficiency. • Retail & Network Expansion • Income from the State Osusala pharmacy network rose by 9%. • Growth was driven by 5 new outlets in Kiribathgoda, Narahenpita, Kegalle, Kalmunai, and Batticaloa. • Several previously loss-making outlets returned to profitability due to efficiency gains. • Operational Milestones • For the first time in its 53-year history, SPC achieved 100% utilization of its annual budget allocation for supplies to the Department of Health Services. • The corporation has initiated ISO 17025 laboratory accreditation to enhance drug quality and safety standards. • National Context As a critical supplier of pharmaceuticals and surgical consumables, the SPC continues to stabilize the healthcare sector by ensuring public access to essential medicines at affordable prices through a rigorous four-stage quality testing process.